Yale Medicine dermatologist Dr. Christopher Bunick explains how studying skin at the atomic level could lead to better eczema ...

Yale Medicine orthopaedic surgeon Dr. Daniel Wiznia explains how this joint-preserving procedure works, how successful it is, ...

CAR-T cell therapy, approved for some blood cancers, is being studied for lupus, MS, and scleroderma. Yale Medicine experts ...

Click here to view more about this specialist's research and educational efforts on https://medicine.yale.edu Click here to view more about this specialist's research and educational efforts onhttps:/ ...

Measles is so contagious that one infected person can spread the respiratory virus to 90% of people in the same room—and it can live in the air for two hours. Often, an infected person doesn’t even ...

Our team-based approach employs gastroenterologist, physician assistants, and a team of nurses and medical assistants to share the responsibilities of our patients’ medical care. Following ...

BMS-986446 for Early Alzheimer’s Disease. BMS-986446 is a monoclonal antibody directed against extracellular tau protein, thereby slowing the toxic spread of this protein in Alzheimer’s disease. This ...

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis stage 2 or 3 and consists of 2 parts - Part 1 and Part 2, with the following primary objectives: Part 1 ...

The Food and Drug Administration (FDA) recently halted sales of surgical mesh devices used for transvaginal repair of pelvic organ prolapse (POP). In this condition, the muscles and tissues that ...

Yale Medicine specialists explain how new oral forms of GLP-1 obesity medications work, how effective they are, and what to consider before switching from the shot. If you’ve been avoiding GLP-1 ...

Note: Information in this article was accurate at the time of original publication. Because information about COVID-19 changes rapidly, we encourage you to visit the websites of the Centers for ...

The prescription pill is said to be nonaddictive. The Food and Drug Administration (FDA) recently approved a new, non-opioid prescription pill—suzetrigine. Sold under the brand name Journavx™, the ...